Gene · 6121
Papers3,325
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 3,325
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Editorial: Gene therapy for the central and peripheral nervous system, volume II. | Front Mol Neurosci | 2023 | 37593465 | PubTator, text mining | PubMed |
| Rapid RGR-dependent visual pigment recycling is mediated by the RPE and specialized Müller glia. | Cell Rep | 2023 | 37585292 | PubTator, text mining | PubMed |
| [Diagnostics and management of patients with inherited retinal diseases in Germany : Results of a nationwide survey of university and non-university eye departments and specialized practices]. | Ophthalmologie | 2023 | 37582888 | PubTator, text mining | PubMed |
| Rod and Cone Function Measured Objectively by Chromatic Pupil Campimetry Show a Different Preservation Between Distinct Genotypes in Retinitis Pigmentosa. | Invest Ophthalmol Vis Sci | 2023 | 37578425 | PubTator, text mining | PubMed |
| Characteristics of Rare Inherited Retinal Dystrophies in Adaptive Optics-A Study on 53 Eyes. | Diagnostics (Basel) | 2023 | 37568834 | PubTator, text mining | PubMed |
| Updates on Functional and Morphologic Features via State-of-the-Art Testing in Some Clinically Evident Ocular Diseases. | J Clin Med | 2023 | 37568454 | PubTator, text mining | PubMed |
| Comparative mechanistic study of RPE cell death induced by different oxidative stresses. | Redox Biol | 2023 | 37566944 | PubTator, text mining | PubMed |
| Cells Special Issue: "The Molecular and Cellular Basis of Retinal Diseases". | Cells | 2023 | 37566012 | PubTator, text mining | PubMed |
| Novel gene signature for predicting biochemical recurrence-free survival of prostate cancer and PRAME modulates prostate cancer progression. | Am J Cancer Res | 2023 | 37559989 | PubTator, text mining | PubMed |
| Dynamic human retinal pigment epithelium (RPE) and choroid architecture based on single-cell transcriptomic landscape analysis. | Genes Dis | 2023 | 37554187 | PubTator, text mining | PubMed |
| Gene therapy of adeno-associated virus (AAV) vectors in preclinical models of ischemic stroke. | CNS Neurosci Ther | 2023 | 37551863 | PubTator, text mining | PubMed |
| Development of a novel prediction model based on protein structure for identifying RPE65-associated inherited retinal disease (IRDs) of missense variants. | PeerJ | 2023 | 37547722 | PubTator, text mining | PubMed |
| CiliaMiner: an integrated database for ciliopathy genes and ciliopathies. | Database (Oxford) | 2023 | 37542408 | PubTator, text mining | PubMed |
| Progress and prospects of gene therapy in ophthalmology from 2000 to 2022: A bibliometric analysis. | Heliyon | 2023 | 37539253 | PubTator, text mining | PubMed |
| Ex vivo cultivated retinal pigment epithelial cell transplantation for the treatment of rabbit corneal endothelial dysfunction. | Eye Vis (Lond) | 2023 | 37528478 | PubTator, text mining | PubMed |
| A multidisciplinary approach to inherited retinal dystrophies from diagnosis to initial care: a narrative review with inputs from clinical practice. | Orphanet J Rare Dis | 2023 | 37525225 | PubTator, text mining | PubMed |
| Genome editing in the treatment of ocular diseases. | Exp Mol Med | 2023 | 37524870 | PubTator, text mining | PubMed |
| Adeno-Associated Virus-Mediated Gene Therapy. | Crit Rev Eukaryot Gene Expr | 2023 | 37522547 | PubTator, text mining | PubMed |
| Bilateral exudative retinal detachments after subretinal gene therapy with voretigene neparvovec-rzyl for RPE65 Leber Congenital Amaurosis. | Am J Ophthalmol Case Rep | 2023 | 37521805 | PubTator, text mining | PubMed |
| AAV5-mediated manipulation of insulin expression in choroid plexus has long-term metabolic and behavioral consequences. | Cell Rep | 2023 | 37515772 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6121/papers?page=16